May 17, 2020

Top celebrity personal trainers

personal trainer
4 min
Mark Anthony
Personal trainers are a luxury exercising accessory; a knowledgeable guide and inspiration in the quest for ultimate health and fitness. Available at m...

Personal trainers are a luxury exercising accessory; a knowledgeable guide and inspiration in the quest for ultimate health and fitness. Available at most gyms, personal trainers are not rare beings but they are expensive. The celebrity desire for a perfect figure or a wash-board stomach is massive and they seek the services of a personal trainer like a lioness hunting her prey. This has turned the very idea of a personal trainer into a desirable status symbol and as a result the price for these services has rocketed.

With products like cars, jewellery and houses, there are only a select few brands that service the mega-stars of today and personal trainers are no exception; only a handful are good enough for the job. Healthcare Global has taken a look into the top celebrity personal trainers to see what makes them special.

Michal George

With the accolade of one of Hollywood’s most sought after personal trainers, Michael George has worked with top celebrities like Meg Ryan, Toby Maguire and Reese Witherspoon. Not only does George act as a personal trainer to the stars he also provides boot camps, nutrition classes, healthy lifestyle coaching and wellness programmes.

George describes his training style as “unique” and he says that he specialises in “reduction of body fat, stress reduction, strength and pain rehabilitation.” He also says he utilises “a total body approach that focuses on lifestyle transformation.” He adds: “What I do is functional fitness for daily living and I help clients create lifestyle that supports healthy living.”

“Follow an exercise regime that is right for your body and personal goals,” he advises. “Always strive to raise the bar and intensity of your workouts.”

Tracy Anderson

Tracy Anderson is another huge name in personal fitness, having sculpted the bodies of Gwyneth Paltrow and Matthew McConaughey. She has spent 10 years researching exercise processes and fitness methods to create her own innovative approach; targeting the small muscle groups to achieve long, lean muscles without the bulky muscular look.

Anderson has also designed the Hybrid Body Reformer, a product the fuses aerobics and dance to regenerate and re-engineer the muscle structure, helping her clients to achieve defined and toned bodies with firm and smooth skin. To match the ‘Tracy Anderson Method’ that she has created, her state-of-the-art studios across America have been designed specifically to work alongside her method.

Matt Roberts

Another world leader in personal fitness terms, Matt Roberts opened the first exclusive one-to-one training center in London in 1995. He now works with the likes of Naomi Campbell and John Galliano and has four gyms across the capital; in Hampstead, Chelsea, Mayfair and The City. The Matt Roberts team consists of highly skilled personal trainers, physiotherapists, dieticians and biomechanics experts.

Aside from personal training, the Matt Roberts brand offers services such as Pilates, a running clinic and Nordic walking and all are designed to maximise your health and fitness development. Roberts is a firm believer that there are no shortcuts when it comes to exercising: “The problem is the ‘achieve everything now’ mentality.” He adds: “People want short cuts or a magic pill that simply does not exist. To achieve the body you truly want takes hard work, discipline and focus.”  

Mark Anthony

Also known as the ‘body genius’, Mark Anthony is a leading health and fitness guru. With clients ranging from Hollywood actors to top musicians, he is a man in demand. To differentiate himself from other personal trainers he has developed ‘Body Systems’; a globally renowned fitness programme based on cutting-edge scientific research.  It is through this system that he and his team have guided over 2000 people in their quest for fitness.

His fitness book and exercise DVD ‘Once a Week Workout’ have received international acclaim and in another move to develop the Mark Anthony brand internationally he provides a seven-day residential boot camp in Spain. He is also tapping into the digital side of fitness and has developed a selection of podcasts so that his a-list clients can take their Body Systems programme with them as they jet across the world.

Share article

Apr 30, 2021

The challenges to vaccine distribution affecting everyone

Jonathan Colehower
5 min
The challenges to vaccine distribution affecting everyone
Jonathan Colehower, CEO at CargoChain, describes the COVID-19 vaccine distribution challenges impacting every country, organisation and individual...

While it is comforting to know that vaccines against COVID-19 are showing remarkable efficacy, the world still faces intractable challenges with vaccine distribution. Specifically, the sheer number of vaccines required and the complexity of global supply chains are sure to present problems we have neither experienced nor even imagined. 

Current projections estimate that we could need 12-15 billion doses of vaccine, but the largest vaccine manufacturers produce less than half this volume in a year. To understand the scale of the problem, imagine stacking one billion pennies – you would have a stack that is 950 miles high. Now, think of that times ten. This is a massive problem that one nation can’t solve alone.  

Production capacity 

Even if we have a vaccine – can we make enough? Based on current projections, Pfizer expects to produce up to 1.3 billion doses this year. Moderna is working to expand its capacity to one billion units this year. Serum Institute of India, the world’s largest vaccine producer, is likely to produce 60% of the 3 billion doses committed by AstraZeneca, Johnson & Johnson and Sanofi. This leaves us about 7 billion doses short. 

Expanding vaccine production for most regions in the world is complicated and time-consuming. Unlike many traditional manufacturing operations that can expand relatively quickly and with limited regulation, pharmaceutical production must meet current good manufacturing practice (CGMP) guidelines. So, not only does it take time to transition from R&D to commercial manufacturing, but it could also take an additional six months to achieve CGMP certification. 

The problem becomes even more complex when considering the co-products required. Glass vials and syringes are just two of the most essential co-products needed to produce a vaccine. Last year, before COVID-19, global demand for glass vials was 12 billion. Even if it is safe to dispense ten doses per vial, there is certain to be significant pressure on world supply of the materials needed to package and distribute a vaccine.

It is imperative drug manufacturers and their raw material suppliers have clear visibility of production plans and raw material availability if there is any hope of optimizing scarce resources and maximising production yield.

Distribution requirements

It is widely known by now that temperature is a critical factor for the COVID-19 vaccine. Even the regions with the most developed logistics infrastructures and resources needed to support a cold-chain network are sure to struggle with distribution.

For the United States alone, State and local health agencies have determined distribution costs will exceed $8.4 billion, including $3 billion for workforce recruitment and training; $1.2 billion for cold-chain, $1 billion vaccination sites and $0.5 billion IT upgrades.  

The complexity of the problem increases further when considering countries such as India that do not have cold-chain logistics networks that meet vaccine requirements. Despite India’s network of 28,000 cold-chain units, none are capable of transporting vaccines below -25°Celsius. While India’s Serum Institute has licensed to manufacture AstraZeneca’s vaccine, which can reportedly be stored in standard refrigerated environments, even a regular vaccine cold chain poses major challenges.

Furthermore, security will undoubtedly become a significant concern that global authorities must address with a coordinated solution. According to the Pharmaceutical Security Institute, theft and counterfeiting of pharmaceutical products rose nearly 70% over the past five years. As with any valuable and scarce product, counterfeits will emerge. Suppliers and producers are actively working on innovative approaches to limit black-market interference. Corning, for example, is equipping vials with black-light verification to curb counterfeiting.

Clearly, this is a global problem that will require an unprecedented level of collaboration and coordination.

Disconnected information systems 

While it is unreasonable to expect every country around the world will suddenly adopt a standard technology that would provide immediate, accurate and available information for everyone, it is not unreasonable to think that we can align on a standard taxonomy that can serve as a Rosetta Stone for collaboration. 

A shared view of the situation (inventory, raw materials, delivery, defects) will provide every nation with the necessary information to make life-saving decisions, such as resource pooling, stock allocations and population coverage.

By allowing one central authority, such as the World Health Organization, to organize and align global leaders to a single collaboration standard, such as GS1, and a standard sharing protocol, such as DSCSA, then every supply chain participant will have the ability to predict, plan and execute in a way that maximises global health.

Political influence and social equality 

As if we don’t have enough stress and churn in today’s geopolitical environment, we must now include the challenge of “vaccine nationalism.” While this might not appear to be a supply chain problem, per se, it is a critical challenge that will hinge on supply chain capabilities.

In response to the critical supply issues the world experienced with SARS-CoV-2, the World Health Organization, Gavi, the Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI) formed Covax: a coalition dedicated to equitable distribution of 2 billion doses of approved vaccines to its 172 member countries. Covax is currently facilitating a purchasing pool and has made commitments to buy massive quantities of approved vaccines when they become available.  

However, several political powerhouse countries, such as the United States and Russia, are not participating. Instead, they are striking bilateral deals with drug manufacturers – essentially, competing with the rest of the world to secure a national supply. Allocating scarce resources is never easy, but when availability could mean the difference between life and death, it becomes almost impossible.

Global production, distribution and social equality present dependent yet conflicting realities that will demand global supply chains provide complete transparency and an immutable chain of custody imperative to vaccine distribution. 

The technology is available today – we just need to use it. We have the ability to track every batch, pallet, box, vile and dose along the supply chain. We have the ability to know with absolute certainty that the vaccine is approved, where and when it was manufactured, how it was handled and whether it was compromised at any point in the supply chain. Modern blockchain technologies should be applied so that every nation, institution, regulator, doctor and patient can have confidence in knowing that they are making an impact in eradicating COVID-19.

Share article